163 related articles for article (PubMed ID: 33479581)
1. Role of fatty acid elongase Elovl6 in the regulation of energy metabolism and pathophysiological significance in diabetes.
Matsuzaka T
Diabetol Int; 2021 Jan; 12(1):68-73. PubMed ID: 33479581
[TBL] [Abstract][Full Text] [Related]
2. [Role of Fatty Acid Elongase Elovl6 in the Regulation of Fatty Acid Quality and Lifestyle-related Diseases].
Matsuzaka T; Shimano H
Yakugaku Zasshi; 2022; 142(5):473-476. PubMed ID: 35491151
[TBL] [Abstract][Full Text] [Related]
3. Elovl6 Deficiency Improves Glycemic Control in Diabetic
Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice.
Matsuzaka T; Kuba M; Koyasu S; Yamamoto Y; Motomura K; Arulmozhiraja S; Ohno H; Sharma R; Shimura T; Okajima Y; Han SI; Aita Y; Mizunoe Y; Osaki Y; Iwasaki H; Yatoh S; Suzuki H; Sone H; Takeuchi Y; Yahagi N; Miyamoto T; Sekiya M; Nakagawa Y; Ema M; Takahashi S; Tokiwa H; Shimano H
Hepatology; 2020 May; 71(5):1609-1625. PubMed ID: 31529722
[TBL] [Abstract][Full Text] [Related]
5. Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance.
Moon YA; Ochoa CR; Mitsche MA; Hammer RE; Horton JD
J Lipid Res; 2014 Dec; 55(12):2597-605. PubMed ID: 25281760
[TBL] [Abstract][Full Text] [Related]
6. Elovl6: a new player in fatty acid metabolism and insulin sensitivity.
Matsuzaka T; Shimano H
J Mol Med (Berl); 2009 Apr; 87(4):379-84. PubMed ID: 19259639
[TBL] [Abstract][Full Text] [Related]
7. Ablation of Elovl6 protects pancreatic islets from high-fat diet-induced impairment of insulin secretion.
Tang N; Matsuzaka T; Suzuki M; Nakano Y; Zao H; Yokoo T; Suzuki-Kemuriyama N; Kuba M; Okajima Y; Takeuchi Y; Kobayashi K; Iwasaki H; Yatoh S; Takahashi A; Suzuki H; Sone H; Shimada M; Nakagawa Y; Yahagi N; Yamada N; Shimano H
Biochem Biophys Res Commun; 2014 Jul; 450(1):318-23. PubMed ID: 24938128
[TBL] [Abstract][Full Text] [Related]
8. Novel qualitative aspects of tissue fatty acids related to metabolic regulation: lessons from Elovl6 knockout.
Shimano H
Prog Lipid Res; 2012 Jul; 51(3):267-71. PubMed ID: 22266797
[TBL] [Abstract][Full Text] [Related]
9. Elovl6 promotes nonalcoholic steatohepatitis.
Matsuzaka T; Atsumi A; Matsumori R; Nie T; Shinozaki H; Suzuki-Kemuriyama N; Kuba M; Nakagawa Y; Ishii K; Shimada M; Kobayashi K; Yatoh S; Takahashi A; Takekoshi K; Sone H; Yahagi N; Suzuki H; Murata S; Nakamuta M; Yamada N; Shimano H
Hepatology; 2012 Dec; 56(6):2199-208. PubMed ID: 22753171
[TBL] [Abstract][Full Text] [Related]
10. 5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a potent inhibitor for mammalian elongase of long-chain fatty acids family 6: examination of its potential utility as a pharmacological tool.
Shimamura K; Kitazawa H; Miyamoto Y; Kanesaka M; Nagumo A; Yoshimoto R; Aragane K; Morita N; Ohe T; Takahashi T; Nagase T; Sato N; Tokita S
J Pharmacol Exp Ther; 2009 Jul; 330(1):249-56. PubMed ID: 19359527
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of elongase of very long-chain fatty acids 6 (elovl6) genes in Misgurnus anguillicaudatus and their potential roles in adaptation to cold temperature.
Chen J; Cui Y; Yan J; Jiang J; Cao X; Gao J
Gene; 2018 Aug; 666():134-144. PubMed ID: 29733968
[TBL] [Abstract][Full Text] [Related]
12. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.
Matsuzaka T; Shimano H; Yahagi N; Kato T; Atsumi A; Yamamoto T; Inoue N; Ishikawa M; Okada S; Ishigaki N; Iwasaki H; Iwasaki Y; Karasawa T; Kumadaki S; Matsui T; Sekiya M; Ohashi K; Hasty AH; Nakagawa Y; Takahashi A; Suzuki H; Yatoh S; Sone H; Toyoshima H; Osuga J; Yamada N
Nat Med; 2007 Oct; 13(10):1193-202. PubMed ID: 17906635
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid elongase 6 plays a role in the synthesis of long-chain fatty acids in goat mammary epithelial cells.
Shi HB; Wu M; Zhu JJ; Zhang CH; Yao DW; Luo J; Loor JJ
J Dairy Sci; 2017 Jun; 100(6):4987-4995. PubMed ID: 28390727
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.
Yew Tan C; Virtue S; Murfitt S; Roberts LD; Phua YH; Dale M; Griffin JL; Tinahones F; Scherer PE; Vidal-Puig A
Sci Rep; 2015 Dec; 5():18366. PubMed ID: 26679101
[TBL] [Abstract][Full Text] [Related]
15. Modulation of palmitate-induced endoplasmic reticulum stress and apoptosis in pancreatic β-cells by stearoyl-CoA desaturase and Elovl6.
Green CD; Olson LK
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E640-9. PubMed ID: 21266672
[TBL] [Abstract][Full Text] [Related]
16. Absence of Elovl6 attenuates steatohepatitis but promotes gallstone formation in a lithogenic diet-fed Ldlr(-/-) mouse model.
Kuba M; Matsuzaka T; Matsumori R; Saito R; Kaga N; Taka H; Ikehata K; Okada N; Kikuchi T; Ohno H; Han SI; Takeuchi Y; Kobayashi K; Iwasaki H; Yatoh S; Suzuki H; Sone H; Yahagi N; Arakawa Y; Fujimura T; Nakagawa Y; Yamada N; Shimano H
Sci Rep; 2015 Dec; 5():17604. PubMed ID: 26619823
[TBL] [Abstract][Full Text] [Related]
17. Advanced Oxidation Protein Products Contribute to Renal Tubulopathy
Imafuku T; Watanabe H; Satoh T; Matsuzaka T; Inazumi T; Kato H; Tanaka S; Nakamura Y; Nakano T; Tokumaru K; Maeda H; Mukunoki A; Takeo T; Nakagata N; Tanaka M; Matsushita K; Tsuchiya S; Sugimoto Y; Shimano H; Fukagawa M; Maruyama T
Kidney360; 2020 Aug; 1(8):781-796. PubMed ID: 35372949
[TBL] [Abstract][Full Text] [Related]
18. Discovery and characterization of a novel potent, selective and orally active inhibitor for mammalian ELOVL6.
Shimamura K; Nagumo A; Miyamoto Y; Kitazawa H; Kanesaka M; Yoshimoto R; Aragane K; Morita N; Ohe T; Takahashi T; Nagase T; Sato N; Tokita S
Eur J Pharmacol; 2010 Mar; 630(1-3):34-41. PubMed ID: 20045404
[TBL] [Abstract][Full Text] [Related]
19. Two modes of regulation of the fatty acid elongase ELOVL6 by the 3-ketoacyl-CoA reductase KAR in the fatty acid elongation cycle.
Naganuma T; Kihara A
PLoS One; 2014; 9(7):e101823. PubMed ID: 25003994
[TBL] [Abstract][Full Text] [Related]
20. [SREBP-1c and Elovl6 as Targets for Obesity-related Disorders].
Shimano H
Yakugaku Zasshi; 2015; 135(9):1003-9. PubMed ID: 26329544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
